Caliper Life Sciences Up 7.3% On Preliminary Results (CALP)

Shares of Caliper Life Sciences Inc. (Nasdaq:

) are trading up 7.3% at $6.05 per share during the Thursday afternoon trading session. On Thursday morning before the market opened, the company announced preliminary 4th quarter revenue results of $36.0 million, which exceeded the upper end of its previous revenue guidance by about $2.5 million. The day's range for shares of Caliper Life Sciences Inc has been between $5.70 and $6.17 per share. The average price target of analysts who cover Caliper Life Sciences Inc. (

CALP

) is $8.00 per share. Volume of 192,000 shares is is still below the daily average volume of 241,000 shares. Caliper Life Sciences Inc. (

CALP

) is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. Read more

from Benzinga's Company news.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.